Company Filing History:
Years Active: 2025
Title: Innovations in ALS Treatment by William Guyer
Introduction
William Guyer is an accomplished inventor based in Menlo Park, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). His innovative approach focuses on the use of a specific compound, dazucorilant, to improve patient outcomes.
Latest Patents
William Guyer holds a patent for "Treatments for amyotrophic lateral sclerosis using dazucorilant." This patent discloses methods and compositions for treating patients suffering from ALS through the administration of a heteroaryl ketone fused azadecalin compound. The compound, dazucorilant, is characterized by its complex chemical structure and has shown promise in enhancing patient care. Suitable doses for administration include daily doses of 150 milligrams and 300 milligrams, which can be taken with food or water. The administration of dazucorilant is effective in increasing exposure to the compound, potentially doubling its effectiveness when used consistently over a week or more.
Career Highlights
William Guyer is associated with Corcept Therapeutics Incorporated, where he continues to develop innovative treatments for ALS. His work is pivotal in advancing therapeutic options for patients facing this challenging condition. With a focus on pharmaceutical compositions that include dazucorilant, Guyer's contributions are shaping the future of ALS treatment.
Collaborations
William collaborates with talented individuals such as Grace Mann and Iulia Cristina Tudor. Their combined expertise enhances the research and development efforts at Corcept Therapeutics, fostering an environment of innovation and discovery.
Conclusion
William Guyer's work in the field of ALS treatment exemplifies the impact of innovative thinking in medicine. His patent on dazucorilant represents a significant step forward in providing effective therapies for patients. Through his career and collaborations, Guyer continues to contribute to advancements in healthcare.